The Copy-Forward Note and the Wrong Date
You are a medical scribe working with Dr. Okafor in an outpatient cardiology clinic. At 2:00 PM you are drafting a progress note for a follow-up visit. Dr. Okafor asks you to 'copy forward' the prior note from three months ago to save time, then update the interval history. The prior note contains: a medication list including warfarin 5 mg daily, an assessment of 'stable atrial fibrillation,' and a plan to 'continue current therapy.' During today's visit, the patient reports two episodes of palpitations and a nosebleed last week. The nurse's vitals show BP 148/92 and HR 96. Dr. Okafor is called away to an emergency and says, 'Just finish it and I'll sign when I'm back.'
1. What are the documentation risks of copy-forwarding this note, and what must be updated before it is signed?
Read the worked answer
Risks of copy-forwarding:
- Stale data: The prior medication list, assessment, and plan may no longer be accurate. Copying them without verification can propagate errors.
- Omission of new findings: The palpitations and nosebleed are clinically significant, especially with warfarin (bleeding risk). If the note still says 'stable' and 'continue current therapy,' it misrepresents the visit.
- Attribution and audit issues: Copy-forwarded text can obscure who documented what and when; payers and auditors scrutinize cloned notes.
- Liability: A note that contradicts the patient's reported symptoms and vitals is a documentation integrity problem.
Before signing, the note must be updated to reflect: today's date and visit type, the interval history (palpitations, nosebleed), current vitals (BP 148/92, HR 96), a reassessment that addresses the new symptoms, and a plan that considers them (e.g., checking INR, evaluating bleeding). The medication list should be reconciled, not assumed.
2. Dr. Okafor is unavailable and asks you to finish the note. What can a scribe document, and what must the provider do?
Read the worked answer
A scribe can document what was observed and dictated during the encounter - the history as reported, vitals, and the provider's stated findings and plan. A scribe cannot independently make clinical assessments, order tests, or sign the note.
What the provider must do:
- Review the drafted note for accuracy.
- Add or confirm the assessment and plan, especially given the new symptoms.
- Sign and date the note, attesting to its accuracy.
If the provider is unavailable, the note should be left in draft status with a clear flag that the assessment and plan require provider input. The scribe should not sign on the provider's behalf or finalize clinical content. The practice should have a policy on scribe attestation and provider sign-off timing.
3. The next morning, Dr. Okafor signs the note without reading it, and it still says 'stable atrial fibrillation, continue current therapy.' A week later the patient is seen in the ED for an elevated INR and bleeding. What documentation issues does this raise, and what should happen now?
Read the worked answer
Documentation issues:
- The signed note does not reflect the reported palpitations and nosebleed, creating a mismatch between the record and the clinical reality.
- The 'stable' assessment and 'continue current therapy' plan are contradicted by the new symptoms and elevated BP/HR.
- Signing without review undermines the attestation's validity and raises integrity concerns.
What should happen now:
- Do not alter the signed note retroactively to hide the gap; instead, add a late entry or addendum clearly dated and attributed, documenting the omission and the subsequent ED visit.
- Notify the practice manager and, if the practice has one, the compliance or quality officer.
- Review the copy-forward workflow and require provider review before sign-off.
- Consider whether the patient was harmed and whether disclosure or other follow-up is needed per policy.
- Document the corrective action.